BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15622242)

  • 1. Epidermal growth factor in Dupuytren's disease.
    Augoff K; Kula J; Gosk J; Rutowski R
    Plast Reconstr Surg; 2005 Jan; 115(1):128-33. PubMed ID: 15622242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor (EGF-R) in Dupuytren's disease.
    Augoff K; Taboła R; Kula J; Gosk J; Rutowski R
    J Hand Surg Br; 2005 Dec; 30(6):570-3. PubMed ID: 16055243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatinase A activity in Dupuytren's disease.
    Augoff K; Ratajczak K; Gosk J; Tabola R; Rutowski R
    J Hand Surg Am; 2006 Dec; 31(10):1635-9. PubMed ID: 17145384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
    Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.
    Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP
    J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free radicals and Dupuytren's contracture.
    Murrell GA; Francis MJ; Bromley L
    Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1373-5. PubMed ID: 2825907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the fibroblast in Dupuytren's contracture.
    Murrell GA
    Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
    Ulrich D; Ulrich F; Piatkowski A; Pallua N
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cells in Dupuytren's contracture.
    Qureshi FI; Hornigold R; Spencer JD; Hall SM
    J Hand Surg Br; 2001 Aug; 26(4):362-7. PubMed ID: 11469841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupuytren's disease.
    Childs SG
    Orthop Nurs; 2005; 24(2):160-3; quiz 164-5. PubMed ID: 15902016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine structural alterations of the palmar aponeurosis in Dupuytren's contracture. A combined scanning and transmission electronmicroscopic examination.
    Józsa L; Salamon A; Réffy A; Renner A; Demel S; Donhöffer A; Pintér T; Thöring J
    Zentralbl Allg Pathol; 1988; 134(1):15-25. PubMed ID: 3358315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathological study on palmar aponeurosis in Dupuytren's disease.
    Józsa L; Demel S; Pintér T; Renner A; Réffy A; Sántha A; Salamon A
    Acta Histochem; 1988; 83(2):153-8. PubMed ID: 3138883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of palmar aponeuroses from individuals with diabetes mellitus and Dupuytren's contracture.
    Melling M; Reihsner R; Pfeiler W; Schnallinger M; Karimian-Teherani D; Behnam M; Mostler S; Menzel EJ
    Anat Rec; 1999 Aug; 255(4):401-6. PubMed ID: 10409813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the extracellular matrix proteoglycan profile in Dupuytren's contracture affect the palmar fascia.
    Koźma EM; Olczyk K; Wisowski G; Głowacki A; Bobiński R
    J Biochem; 2005 Apr; 137(4):463-76. PubMed ID: 15858170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.